Hello everyone,

I am conducting an assay to measure reactive oxygen species (ROS) using DCFDA (Sigma #D688) in prostate cancer cell lines and have some questions regarding the protocol.

  • Adherent vs. Suspended Cells: Should DCFDA treatment be performed while the cells are still adherent, or is it preferable to detach them before incubation with DCFDA? In my case, I am diluting DCFDA in DMEM (without FBS). My current approach is to treat the cells with DCFDA for 30 minutes while they are adherent and then detach them for analysis.
  • Optimal DCFDA Concentration: I am currently using 10 µM DCFDA, but I observe no significant difference between my positive control and vehicle-treated samples. Could this concentration be too high, leading to signal saturation or other issues? What concentration would you recommend for optimal sensitivity?
  • Positive Control Selection: I am using hydrogen peroxide (H₂O₂) for 20 minutes as my positive control. Is this an appropriate choice, or would you recommend a different ROS-inducing agent for better contrast with the vehicle control?
  • I appreciate any insights or recommendations you can share. Thank you in advance!

    More Mikel Arana's questions See All
    Similar questions and discussions